Wall Street analysts predict that Addus Homecare Co. (NASDAQ:ADUS) will report earnings of $0.54 per share for the current quarter, according to Zacks. Four analysts have made estimates for Addus Homecare’s earnings. The highest EPS estimate is $0.56 and the lowest is $0.51. Addus Homecare posted earnings per share of $0.50 in the same quarter last year, which indicates a positive year-over-year growth rate of 8%. The company is scheduled to issue its next quarterly earnings report on Monday, August 5th.
On average, analysts expect that Addus Homecare will report full-year earnings of $2.36 per share for the current fiscal year, with EPS estimates ranging from $2.28 to $2.55. For the next fiscal year, analysts expect that the company will report earnings of $2.73 per share, with EPS estimates ranging from $2.44 to $3.21. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Addus Homecare.
Addus Homecare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, May 6th. The company reported $0.44 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.40 by $0.04. Addus Homecare had a net margin of 3.20% and a return on equity of 8.95%. The business had revenue of $139.25 million during the quarter, compared to the consensus estimate of $139.37 million.
In related news, Director Mark L. First sold 440,000 shares of the stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $74.08, for a total transaction of $32,595,200.00. Following the completion of the transaction, the director now owns 19,151 shares in the company, valued at $1,418,706.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Brian Poff sold 814 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $67.96, for a total transaction of $55,319.44. Following the transaction, the chief financial officer now owns 18,241 shares of the company’s stock, valued at approximately $1,239,658.36. The disclosure for this sale can be found here. Insiders sold 460,814 shares of company stock valued at $34,061,919 in the last quarter. Corporate insiders own 34.80% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Marshall Wace North America L.P. acquired a new position in Addus Homecare during the first quarter worth $34,000. Bank of Montreal Can boosted its holdings in Addus Homecare by 58.9% during the first quarter. Bank of Montreal Can now owns 545 shares of the company’s stock worth $35,000 after purchasing an additional 202 shares during the last quarter. South Dakota Investment Council acquired a new position in Addus Homecare during the first quarter worth $83,000. BNP Paribas Arbitrage SA boosted its holdings in Addus Homecare by 9,077.3% during the first quarter. BNP Paribas Arbitrage SA now owns 2,019 shares of the company’s stock worth $128,000 after purchasing an additional 1,997 shares during the last quarter. Finally, NumerixS Investment Technologies Inc acquired a new position in Addus Homecare during the first quarter worth $138,000. Institutional investors and hedge funds own 98.99% of the company’s stock.
Shares of NASDAQ:ADUS opened at $74.81 on Wednesday. Addus Homecare has a 52 week low of $55.25 and a 52 week high of $77.82. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.87 and a quick ratio of 2.87. The company has a market capitalization of $983.82 million, a P/E ratio of 44.27, a PEG ratio of 2.30 and a beta of -0.16. The firm has a 50 day moving average price of $70.98.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.